Study identifies new drug target in deadly form of leukemia

A research team led by the Duke-NUS Graduate Medical School in Singapore has identified ways to inhibit the function of a key protein linked to stem cell-like behavior in terminal-stage chronic myeloid leukemia , making it possible to develop drugs that may extend the survival of these patients.

http://medicalxpress.com/news/2013-06-drug-deadly-leukemia.html